08:00 , Jan 13, 2014 |  BioCentury  |  Finance

Buyside View XXII: 'Grown up' means growth

Stephen Hansen Senior Writer  An increase in regulatory approvals and new breakthrough therapies has money managers buying into the concept that biotech has entered a new product cycle that provides a strong fundamental basis for growth....
08:00 , Jan 6, 2014 |  BioCentury  |  Finance

2014 Financial Markets Preview: Hoping the pause is brief

Bankers and buysiders are not expecting a repeat performance of biotech's stellar 2013. But the two dozen who spoke with BioCentury say the capital markets are primed to open back up this month, albeit on...
08:00 , Nov 25, 2013 |  BC Week In Review  |  Financial News

A.P. Pharma completes follow-on

A.P. Pharma Inc. (OTCBB: APPA), Redwood City, Calif.   Business: Drug delivery   Date completed: 11/20/13   Type: Follow-on   Raised: $60 million   Shares: 150 million   Price: $0.40   Shares after offering: 460.9 million   Underwriters: Jefferies; Leerink; JMP Securities;...
08:00 , Nov 25, 2013 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones AB Science S.A. (Euronext:AB) fell €4 (21%) to €15 on Friday after EMA's CHMP issued a negative opinion recommending against approval of an MAA for Masican masitinib to treat gastrointestinal stromal tumors (GIST) that...
00:55 , Nov 21, 2013 |  BC Extra  |  Financial News

A.P. Pharma raises $60 million in follow-on

A.P. Pharma Inc. (OTCBB:APPA) raised $60 million through the sale of 150 million shares at $0.40 in a follow-on underwritten by Jefferies; Leerink Swan; JMP Securities; Brean Capital; and Oppenheimer. A.P. Pharma proposed the offering...
08:00 , Nov 11, 2013 |  BC Week In Review  |  Company News

A.P. Pharma management update

A.P. Pharma Inc. (OTCBB:APPA), Redwood City, Calif.   Business: Drug delivery   Hired: Brian Drazba as VP of finance and CFO, formerly VP of finance and chief accounting officer of Ista Pharmaceuticals Inc., which Bausch...
07:00 , Aug 12, 2013 |  BC Week In Review  |  Financial News

A.P. Pharma financial update

A.P. Pharma's board also approved proposals to change its name to "Heron Therapeutics Inc." and implement a reverse stock split at a ratio between 1-for-10 and 1-to-20. The company will also seek a listing on...
07:00 , May 13, 2013 |  BC Week In Review  |  Company News

A.P. Pharma management update

A.P. Pharma Inc. (OTCBB:APPA), Redwood City, Calif.   Business: Drug delivery   Hired: Steve Davis, a director, as EVP and COO, formerly EVP and COO of Ardea Biosciences Inc., which AstraZeneca plc acquired; and Barry...
07:00 , Apr 1, 2013 |  BC Week In Review  |  Clinical News

APF530 regulatory update

A.P. Pharma said FDA issued a second complete response letter for an NDA for APF530 to prevent chemotherapy-induced nausea and vomiting (CINV). According to the company, FDA did not request new clinical studies, but did...
08:00 , Dec 17, 2012 |  BC Week In Review  |  Company News

A.P. Pharma management update

A.P. Pharma Inc. (OTCBB:APPA), Redwood City, Calif.   Business: Drug delivery   Hired: Mark Gelder as SVP and CMO, formerly VP and global head of medical affairs at the medical diagnostics business of the GE Healthcare unit...